XTX Topco’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-72,766
| Closed | -$294K | – | 2450 |
|
|
2025
Q1 | $294K | Buy |
+72,766
| New | +$243K | 0.02% | 1425 |
|
|
2024
Q4 | – | Sell |
-18,033
| Closed | -$40.4K | – | 2367 |
|
|
2024
Q3 | $40.4K | Buy |
18,033
+2,428
| +16% | +$5.6K | ﹤0.01% | 1724 |
|
|
2024
Q2 | $33.6K | Buy |
+15,605
| New | +$27.8K | ﹤0.01% | 1551 |
|
|
2023
Q4 | – | Sell |
-20,941
| Closed | -$35.6K | – | 1661 |
|
|
2023
Q3 | $35.6K | Buy |
+20,941
| New | +$47.6K | 0.01% | 1318 |
|
|
2023
Q2 | – | Sell |
-10,125
| Closed | -$22.8K | – | 1459 |
|
|
2023
Q1 | $22.8K | Buy |
+10,125
| New | +$50.8K | ﹤0.01% | 1207 |
|
|
2021
Q3 | – | Sell |
-1,622
| Closed | -$48K | – | 736 |
|
|
2021
Q2 | $48K | Buy |
1,622
+438
| +37% | +$12.1K | 0.02% | 728 |
|
|
2021
Q1 | $37K | Buy |
+1,184
| New | +$39.7K | 0.02% | 638 |
|
XTX Topco's CKPT Position: Q2 2025 in Review
XTX Topco sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 72,766 shares — an estimated $294K sold.
XTX Topco first reported a position in CKPT in Q1 2021 and held it in 7 quarters. The position peaked at $294K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- XTX Topco reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- XTX Topco sold 72,766 Checkpoint Therapeutics shares in Q2 2025, an estimated $294K.
- XTX Topco first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 7 quarters.
- XTX Topco's Checkpoint Therapeutics position peaked at $294K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.